You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. SUBCUTANEOUS MONITOR/ALARM FOR CARDIAC ARREST

    SBC: AJ MEDICAL DEVICES, INC.            Topic: N/A

    It is estimated that 220,000 people suffer cardiac arrest each year in the US, of whom only 10,000 survive to hospital discharge. The number of survivors could increase 10-fold if paramedical attention and/or defibrillation were available within a few min

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. SCREENING DEVICE FOR DETECTING SMALL ACOUSTIC TUMORS

    SBC: BIO-LOGIC SYSTEMS CORPORATION            Topic: N/A

    N/A

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  3. PORTABLE DEVICE FOR INSTANT DIAGNOSIS OF PNEUMOTHORAX

    SBC: BIOMEDICAL ACOUSTICS RESEARCH COMPANY            Topic: N/A

    DESCRIPTION (Verbatim from the Applicant's Abstract): Pneumothorax refers to air accumulation in the space between the lung and the chest wall. The many potential causes include spontaneous rupture of small alveoli or blebs, progression of inflammatory diseases, complications of diagnostic or therapeutic procedures, plus penetrating (e.g., knife or bul ...

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  4. CONCENTRATED AEROSOL DELIVERY AND QUANTIZATION SYSTEM

    SBC: BIOTECHPLEX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): BioTechPlex Corporation proposes to develop an improved aerosol delivery system. The proposed system, Concentrated Aerosol Delivery and Quantization System, CADAQS, will fulfill the need to acutely deliver high particle number concentrations of aerosols to the respiratory tract of small animals (ra ...

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  5. FIBER-OPTIC-LINKED PRESSURE SENSOR (FOLPS)

    SBC: BIOTECHPLEX CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): There is a critical need and very large market for a miniature ultra-low pressure transducer to monitor pressure within confined body spaces for both animal and human application. Thus, BioTechPlex proposes to de

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Enhanced Long-Term Care of Severe Respiratory Failure

    SBC: COMPACT MEMBRANE SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Current management of acute respiratory distress syndrome (ARDS) is suboptimal. Arteriovenous carbon dioxide removal (AVCO2R) combined with mild oxygen ventilation has shown promise. AVCO2R is mild pumpless technique u

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  7. High Permeability, Long-Wear Contact Lens Materials

    SBC: COMPACT MEMBRANE SYSTEMS, INC.            Topic: N/A

    N/A

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  8. ANTAGONISTS OF PAR1-GQ INTERACTION

    SBC: CUE BIOTECH, INC.            Topic: N/A

    N/A

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Antibiotic Regulatory Genes and Metabolic Engineering

    SBC: FERMALOGIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Strain improvement of commercial fermentations helps to reduce the cost of production of existing pharmaceuticals and helps industry to meet the growing demands for desperately needed new products, such as antibiotics, that can be produced in large enough quantities and at prices the public can afford. This project ...

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  10. Antibiotic Gene Clusters

    SBC: FERMALOGIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Strain improvement of industrial microorganisms is required at both the clinical testing stage and commercialization stage of drug development. Although strain improvement plays an enormous economic role in reducing t

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government